TAP

The headline is ugly — FY2025 swung to a net loss of -$2.14B (EPS -$10.75) and a -$2.34B operating loss — but the cash tells a calmer story. Revenue fell only 5.1% to $13.0B and gross profit stayed firmly positive at $4.27B (32.8% margin), yet operating income went deeply negative. With operating cash flow still robust at $1.78B (down only 6.6%), the loss is overwhelmingly non-cash: a large impairment/write-down sits between gross profit and operating income. In plain terms, management marked down the carrying value of brands/acquisitions rather than burning cash. After $717M of capex, free cash flow is roughly $1.06B, which covered $376M of dividends and $648M of buybacks — shareholder returns are intact, if no longer comfortably over-covered.

The problem the impairment is pricing in is real and structural. Revenue has rolled over from the FY2023 peak of $13.9B to $13.0B, and the MD&A is candid that the U.S. beer industry is seeing 'heightened competitive activity and associated reduction in market share of our products,' with the risk that 'market share losses are sustained.' Layer on tariff-driven cost pressure — the Midwest Premium aluminum spike cost ~$35M in 2025 and is 'expected to continue to adversely impact our results' — plus a fresh CEO (Rahul Goyal, effective Oct 2025) and an October 2025 Americas Restructuring Plan. This is a company defending share and cutting costs, not one compounding. The Fevertree investment/acquisition is a sensible premiumization and beyond-beer hedge, but it's small relative to the core volume decline.